Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies
about
Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine developmentAn alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.Immune regulation in Epstein-Barr virus-associated diseasesCrossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune diseaseTransformation-associated Epstein-Barr virus antigens as targets for immune attack.
P2860
Q24814428-33049BBF-CA26-48FD-8112-DE58A2D20397Q30452144-A637549D-E184-4D2B-B962-AB2AD6BA83FEQ30452157-500BB733-CCD6-421B-B5E6-7C74666136FDQ33825567-882CEBA6-3CA7-4E36-804D-7013B22249BBQ35731386-F7709FD8-377D-4A79-AADD-B15010D1C467Q36231451-CFB6ABDD-ABC6-48E3-AF5B-0870462938CCQ36362943-1EE5FDBB-7633-4A60-8050-48D30196B7A1Q36669953-D7E3F98C-CBCE-4E60-8228-CE1B259D2208Q37180193-F25D6963-817F-4CB2-AE98-74B761958151Q40489821-DF92165D-6C65-4C33-98E3-49B9F73530C0
P2860
Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Nonresponsiveness to an immuno ...... cations for vaccine strategies
@en
Nonresponsiveness to an immuno ...... ations for vaccine strategies.
@nl
type
label
Nonresponsiveness to an immuno ...... cations for vaccine strategies
@en
Nonresponsiveness to an immuno ...... ations for vaccine strategies.
@nl
prefLabel
Nonresponsiveness to an immuno ...... cations for vaccine strategies
@en
Nonresponsiveness to an immuno ...... ations for vaccine strategies.
@nl
P2093
P2860
P921
P356
P1476
Nonresponsiveness to an immuno ...... cations for vaccine strategies
@en
P2093
P2860
P304
P356
10.1073/PNAS.88.21.9478
P407
P577
1991-11-01T00:00:00Z